Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe
Bron
Blood advances - ISSN 2473-9529-9:24 (2025) p. 6380-6393
Comparative efficacy of talquetamab vs. real-world physician's choice of treatment in triple-class-exposed relapsed/refractory multiple myeloma : updated analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent
Bron
Advances in therapy : the international journal of drug, device & diagnostic research - ISSN 0741-238X- (2025) p.
Downregulation of MICA/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasia
Bron
Leukemia - ISSN 0887-6924- (2025) p.
Expanding the CAR toolbox with high throughput screening strategies for CAR domain exploration : a comprehensive review
Bron
Journal for ImmunoTherapy of Cancer - ISSN 2051-1426-13:4 (2025) p. 1-13
Dynamics of SERPINA3 in response to anthracycline treatment and cardiovascular dysfunction
Bron
Cardio-Oncology - ISSN 2057-3804-11:1 (2025) p. 1-13